{{Rsnum
|rsid=2229840
|Gene=NCOR2
|Chromosome=12
|position=124341916
|Orientation=minus
|GMAF=0.1469
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=NCOR2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 26.5 | 72.6
| HCB | 1.5 | 17.6 | 80.9
| JPT | 4.4 | 25.7 | 69.9
| YRI | 0.0 | 19.7 | 80.3
| ASW | 0.0 | 15.8 | 84.2
| CHB | 1.5 | 17.6 | 80.9
| CHD | 0.0 | 18.3 | 81.7
| GIH | 4.0 | 29.7 | 66.3
| LWK | 0.0 | 25.5 | 74.5
| MEX | 10.3 | 29.3 | 60.3
| MKK | 0.6 | 26.3 | 73.1
| TSI | 3.9 | 29.4 | 66.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=20003447
|Title=Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
|OA=1
}}

{{GET Evidence
|gene=NCOR2
|aa_change=Ala1706Thr
|aa_change_short=A1706T
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2229840
|overall_frequency_n=1535
|overall_frequency_d=10672
|overall_frequency=0.143834
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=0
|n_articles_annotated=0
|nblosum100=1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}